qlh11906

Advanced Solid Tumors Harboring MAPK Pathway Alterations

Qilu Pharmaceutical Co., Ltd.Phase 1

—

Rating in progress

qlh11906 in Advanced Solid Tumors Harboring MAPK Pathway Alterations is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Active